AKT1 and nasopharyngeal carcinoma: Several studies have shown that the anticancer effects of COX-2 inhibitors on NPC cells result from blocking cell cycle and inducing cell apoptosis, which may be partly mediated through the STAT3 pathway or through the inhibition of AKT phosphorylation[51, 52].